日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient-centered care strategies for Jehovah's Witnesses with acute leukemia and high-grade myeloid neoplasms

针对患有急性白血病和高级别髓系肿瘤的耶和华见证人的以患者为中心的护理策略

Zarka, Jabra; Al-Kali, Aref; Alkhateeb, Hassan B; Matin, Aasiya; Gangat, Naseema; Hogan, William J; Foran, James; Murthy, Hemant; Yi, Cecilia Arana; Prasad, Dhauna Karam; Mina, Syeda; Litzow, Mark R; Begna, Kebede H; Saliba, Antoine N

Characteristics of patients with newly diagnosed acute myeloid leukemia not receiving treatment

未接受治疗的新诊断急性髓系白血病患者的特征

Alkabbani, Oudai; Jabban, Yazan; He, Rong; Viswanatha, David; Bessonen, Kurt; Greipp, Patricia; Jevremovic, Dragan; Foran, James M; Badar, Talha; Yi, Cecilia Arana; Kusne, Yael; Saliba, Antoine N; Hefazi, Mehrdad; Matin, Aasiya; Hogan, William J; Mangaonkar, Abhishek; Alkhateeb, Hassan; Patnaik, Mrinal; Shah, Mithun; Begna, Kebede; Litzow, Mark R; Al-Kali, Aref

Outcomes of hemophagocytic lymphohistiocytosis in acute myeloid leukemia: the 3-site Mayo Clinic experience

急性髓系白血病合并噬血细胞性淋巴组织细胞增生症的预后:梅奥诊所三中心经验

Zarka, Jabra; Csizmar, Clifford M; Mina, Syeda; Hickman, Ashley; Andres, Erica; Matin, Aasiya; Gangat, Naseema; Badar, Talha; Mangaonkar, Abhishek A; Patnaik, Mrinal M; Litzow, Mark R; Hogan, William J; Torghabeh, Mehrdad Hefazi; Foran, James M; Yi, Cecilia Arana; Shah, Mithun V; Begna, Kebede H; Al-Kali, Aref; Alkhateeb, Hassan B; Saliba, Antoine N

Treatment-specific prognostic performance of ELN 2022, ELN 2024, and Beat AML 2024: a real-world AML validation study

ELN 2022、ELN 2024 和 Beat AML 2024 治疗特异性预后性能:一项真实世界 AML 验证研究

Kewan, Tariq; Alkabbani, Oudai; Zureigat, Hadil; He, Rong; Jevremovic, Dragan; Greipp, Patricia; Saliba, Antoine; Matin, Aasiya; Torghabeh, Mehrdad Hefazi; Mangaonkar, Abishek; Gangat, Naseema; Hogan, William; Patnaik, Mrinal; Alkhateeb, Hassan; Yi, Cecilia Arana; Foran, James; Litzow, Mark; Shah, Mithun; Begna, Kebede; Al-Kali, Aref

Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort

在独立的国际队列中验证世界卫生组织和国际共识分类指南第五版中TP53突变型髓系肿瘤的分类标准

Shah, Mithun Vinod; Hung, Kevin; Baranwal, Anmol; Wechalekar, Gauri; Al-Kali, Aref; Toop, Carla R; Greipp, Patricia; Kutyna, Monika M; Matin, Aasiya; Ladon, Dariusz; Saliba, Antoine; Chen, Dong; Begna, Kebede; Brown, Anna; Rud, Danielle; Litzow, Mark R; Hogan, William J; Bardy, Peter; Badar, Talha; Kumar, Sharad; Yeung, David T; Patnaik, Mrinal M; Foran, James M; He, Rong; Gangat, Naseema; Hefazi, Mehrdad; Scott, Hamish S; Arana Yi, Cecilia Y; Alkhateeb, Hassan; Mangaonkar, Abhishek A; Thomas, Daniel; Hahn, Christopher N; Orazi, Attilio; Arber, Daniel A; Kok, Chung Hoow; Tefferi, Ayalew; Hiwase, Devendra

Allogeneic stem cell transplantation in chronic myelomonocytic leukemia: analysis of post-transplant survival and risk factors in 138 Mayo Clinic patients

异基因造血干细胞移植治疗慢性粒单核细胞白血病:梅奥诊所138例患者移植后生存率及危险因素分析

Alsugair, Ali; Gauto Mariotti, Estefania; Alhousani, Mohammad M; Fathima, Saubia; Yousuf, Muhammad; Bolarinwa, Abiola; Foran, James; Mangaonkar, Abishek A; Litzow, Mark; Murthy, Hemant; Sproat, Lisa; Palmer, Jeanne; Matin, Aasiya; Ayala, Ernesto; Slack, James; Porrata, Luis; Iqbal, Madiha; Khera, Nandita; Punwani, Nathan; Kenderian, Saad; Chhabra, Saurabh; Hogan, William J; Shah, Mithun Vinod; Alkhateeb, Hassan B; Gangat, Naseema; Patnaik, Mrinal; Tefferi, Ayalew

Clinical Outcomes and Treatment Strategies of Adult Transplant-Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High-Risk Criteria

成人移植相关血栓性微血管病的临床结果和治疗策略:统一定义和高危标准的外部验证

Acosta-Medina, Aldo A; Sridharan, Meera; Go, Ronald S; Moyer, Ann M; Leung, Nelson; Willrich, Maria Alice V; Wolf, Robert; Kassis, Rabee; Manasrah, Almothana; Kohorst, Mira A; Durani, Urshila; Matin, Aasiya; Hefazi, Mehrdad; Kenderian, Saad J; Mangaonkar, Abhishek A; Shah, Mithun V; Litzow, Mark R; Hogan, William J; Dingli, David; Alkhateeb, Hassan B

Outcomes of Post-Transplant Rh-GCSF and Decitabine Maintenance Therapy in Patients With High-Risk Myeloid Neoplasm

高危髓系肿瘤患者移植后接受 Rh-G-CSF 和地西他滨维持治疗的疗效

Palmer, Mathias; Baranwal, Anmol; Basmaci, Rami; Hassan, Khalil; Kutzke, Jade; Bartoo, Gabriel; Murthy, Hemant; Foran, James; Mangaonkar, Abhishek A; Hefazi, Mehrdad; Matin, Aasiya; Hogan, William J; Litzow, Mark; Shah, Mithun Vinod; Alkhateeb, Hassan B

Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent

梅奥诊所针对接受维奈托克联合去甲基化药物治疗的新诊断急性髓系白血病患者的遗传风险模型

Gangat, Naseema; Elbeih, Azeem; Ghosoun, Nour; McCullough, Kristen; Aperna, Fnu; Johnson, Isla M; Abdelmagid, Maymona; Al-Kali, Aref; Alkhateeb, Hassan B; Begna, Kebede H; Elliott, Michelle; Mangaonkar, Abhishek; Matin, Aasiya; Saliba, Antoine N; Hefazi Torghabeh, Mehrdad; Litzow, Mark R; Hogan, William; Shah, Mithun; Patnaik, Mrinal M; Pardanani, Animesh; Badar, Talha; Murthy, Hemant; Foran, James; Palmer, Jeanne; Sproat, Lisa; Khera, Nandita; Arana Yi, Cecilia; Yates, Samuel; Sneider, Abigail; Dworkin, Emily; Patel, Anand A; Bazinet, Alexandre; Senapati, Jayastu; Bataller, Alex; DiNardo, Courtney; Kadia, Tapan; Tefferi, Ayalew

Risk of Relapse Post Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With High-Risk Myeloid Neoplasms Based on GvHD Prophylaxis: PTCy Vs. TAC/MTX

基于移植物抗宿主病(GvHD)预防方案,评估高危髓系肿瘤患者接受减低强度预处理异基因造血干细胞移植后复发风险:环磷酰胺(PTCy)与他克莫司/甲氨蝶呤(TAC/MTX)的比较

Hassan, Khalil; Baranwal, Anmol; Kassis, Al Rabee; Braun, Jade; Bartoo, Gabriel; Wolf, Robert; Hefazi, Mehrdad; Matin, Aasiya; Mangoankar, Abhishek; Shah, Mithun V; Litzow, Mark R; Hogan, William J; Dingli, David; Alkhateeb, Hassan B